Research and Development

Showing 15 posts of 9573 posts found.

alexander_triebnigg_panpharma

Panpharma appoints Novartis senior head

July 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, celesio AG, panpharma

Pharma trading group Celesio AG has announced that Alexander Triebnigg has taken over the management of the Brazilian pharma wholesaler …
EFPIA image

Secret EFPIA memo on data transparency leaked

July 22, 2013 Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, EMA, PhRMA, transparency

A memo from the European pharma lobby group EFPIA has revealed that the industry is trying to ‘mobilise’ patient groups …

ASCO: Dispatches from the frontline against cancer

July 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, McConaghie

The growing promise of pharma’s immunotherapy pipeline for cancer was undoubtedly the hottest topic at this year’s ASCO conference. The …
Lucentis image

Lucentis and Avastin equal in efficacy

July 19, 2013 Research and Development, Sales and Marketing Lucentis, Novartis, Roche, avastin

Latest results released this morning from a UK government trial show that off-label use of Roche’s Avastin is just as …

Funding boost for lung cancer ‘map’

July 18, 2013 Research and Development, Sales and Marketing cancer research, lung cancer, tracerx

A new Cancer Research UK study aims to unlock lung cancer’s secrets by tracking how lung tumours develop and evolve …
steven_couldwell_tissue_regenix

Tissue Regenix appoints Sanofi VP

July 18, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing couldwell, tissue regenix

Medical devices firm Tissue Regenix has appointed Steven Couldwell as a non-executive director. With over 14 years of senior management …
lundbeck image

Lundbeck/Otsuka Alzheimer’s drug improves cognition

July 17, 2013 Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka

Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …
winchpharma_lyndon_ceo

WinchPharma appoints new chief executive

July 17, 2013 Manufacturing and Production, Research and Development, Sales and Marketing lyndon nicholson, winchpharma

Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect.  Nicholson will replace former …
Brain scan image

Dementia rates declining in UK

July 17, 2013 Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia

A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …
syntaxin image

Ipsen buys Syntaxin

July 16, 2013 Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi

French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …

Roche ‘considers’ Alexion bid

July 16, 2013 Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris

Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …

The pharma industry in the public imagination

July 16, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma

Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …

Aesica appoints two new business development managers

July 16, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas

Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …
lilly image

Lilly revisits Alzheimer’s drug

July 15, 2013 Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab

Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …
simon_lowth_az

Simon Lowth exits AstraZeneca

July 15, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth

AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …
The Gateway to Local Adoption Series

Latest content